Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 7/Signature 1
From BugSigDB
Needs review
Source: Table S4
Description: Differential abundance at genus levels in baseline and follow-up week-72 (FUw72) of patients with HCV/HIV coinfection
Abundance in Group 1: increased abundance in Patients with HCV/HIV coinfection at FUw72
Revision editor(s): Idiaru angela